
==== Front
Cancer Med
Cancer Med
10.1002/(ISSN)2045-7634
CAM4
Cancer Medicine
2045-7634
John Wiley and Sons Inc. Hoboken

10.1002/cam4.7462
CAM47462
Correction
Correction
Correction to “KBTBD7 promotes non‐small cell lung carcinoma progression by enhancing ubiquitin‐dependent degradation of PTEN”
09 9 2024
9 2024
09 9 2024
13 17 10.1002/cam4.v13.17 e7462© 2024 The Author(s). Cancer Medicine published by John Wiley & Sons Ltd.
https://creativecommons.org/licenses/by/4.0/ This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

10.1002/cam4.4794 source-schema-version-number2.0
cover-dateSeptember 2024
details-of-publishers-convertorConverter:WILEY_ML3GV2_TO_JATSPMC version:6.4.8 mode:remove_FC converted:09.09.2024
==== Body
pmcZou Z, Zhang B, Li Z, Lei L, Sun G, Jiang X, Guan J, Zhang Y, Xu S, Li Q. KBTBD7 promotes non‐small cell lung carcinoma progression by enhancing ubiquitin‐dependent degradation of PTEN. Cancer Med. 2022 Dec;11(23):4544–4554.

In the Abstract section, the text “Immunohistochemical staining of 104 paired NSCLC and peritumoral normal specimens indicated that KBTBD7 was highly expressed in NSCLC tissues and positively correlated with the histological type, P‐TNM stage, lymph node metastasis, and tumor size” was incorrect. It should read “Immunohistochemical staining of 102 paired NSCLC and peritumoral normal specimens indicated that KBTBD7 was highly expressed in NSCLC tissues and positively correlated with the histological type, P‐TNM stage, lymph node metastasis, and tumor size.”

In the Method section, 2.1 Patients and specimens “In total, 104 paired NSCLC and peritumoral normal specimens were collected from patients with NSCLC who underwent surgery at the Department of Thoracic Surgery of the First Hospital of China Medical University from 2018 to 2020.” was incorrect. It should read “In total, 102 paired NSCLC and peritumoral normal specimens were collected from patients with NSCLC who underwent surgery at the Department of Thoracic Surgery of the First Hospital of China Medical University from 2018 to 2020.”

In the Result section, 3.1, “KBTBD7 expression in 104 paired NSCLC and adjacent non‐cancerous tissues was assessed by immunohistochemical staining.” was incorrect. It should read “KBTBD7 expression in 102 paired NSCLC and adjacent noncancerous tissues was assessed by immunohistochemical staining.”

In the Result section, 3.2, “Western blot assays indicated that KBTBD7 was expressed at high levels in SK, A549, H1975, H1299, and HCC827 cell lines compared to the HBE cell line (Figure 1C).” was incorrect. It should read “Western blot assays indicated that KBTBD7 was expressed at high levels in A549, SK, H460, H292, and H1299 cell lines compared to the HBE cell line (Figure 1C).”

Figure 3 was incorrect. The correct figure is shown here:

Table 1 was incorrect. The correct table is shown here:

TABLE 1 Correlation of KBTBD7 expression with clinicopathological parameters of NSCLC patients.

Clinicopathological characteristics

	Total N	KBTBD7‐negative	KBTBD7‐positive	p‐Value	
Age (years)	
≤60	53	16	37	0.484	
>60	49	18	31	
Gender	
Male	72	27	45	0.167	
Female	30	7	23	
Histological type	
Squamous cell carcinoma	52	22	30	0.028	
Adenocarcinoma	50	11	39	
Differentiation	
Well‐moderate	61	19	42	0.568	
Poor	41	15	26	
Tumor size (cm)	
≤3	37	19	18	<0.01	
>3	65	15	50	
Lymph node metastasis	
Negative	52	24	28	0.034	
Positive	50	14	36	
TNM stage	
I–IIA	45	22	23	0.019	
IIB–III	57	15	42	

We apologize for these errors.
